Target intelligence / Profile preview

Ankyrin repeat and SOCS box protein 1 (ASB1)

Target
ASB1
Molecular classification
Other (Ankyrin repeat and SOCS box-containing protein), E3 ubiquitin ligase complex component (as part of a larger complex)
01

Overview

Ankyrin repeat and SOCS box protein 1 (ASB1) is a protein encoded by the ASB1 gene in humans, characterized by the presence of six N-terminal ankyrin repeats and a C-terminal SOCS box domain. ASB1 is a member of the SOCS (Suppressor of Cytokine Signaling) box protein family, which typically function as substrate-recognition components of multimeric E3 ubiquitin ligase complexes, such as the Elongin-Cullin-SOCS box (ECS) complex. Unlike many other SOCS box proteins, ASB1 does not promote ubiquitin-mediated proteasomal degradation of its primary binding substrate (TAB2); instead, it stabilizes TAB2 by inhibiting K48-linked polyubiquitination, enhancing NF-κB and MAPK pathway signaling and promoting pro-inflammatory responses. ASB1 has been associated with several human diseases, including immune dysfunction, cardiovascular conditions, and neurodevelopmental disorders, and it may serve as a genetic/epigenetic marker in those contexts. However, there is no evidence that ASB1 is directly targeted by drugs or established as a therapeutic target.

Other names
Ankyrin repeat and SOCS box containing 1ASB1KIAA1146ASB-1
02

Biological functions

Regulation of protein ubiquitinationSignal transductionModulation of NF-κB and MAPK signalingControl of immune and inflammatory responsesPotential regulation of testis development
03

Disease associations

Inflammation (including septic shock, colitis, and immune response modulation)Cardiovascular disease (methylation associated with left ventricular performance in ischemic cardiomyopathy)Psychiatric/neurological disease (epigenetic modification involved in anxiety-related immune dysregulation)Cardiovascular development (atrial septal defect association)Neurodevelopmental disorder (autism spectrum disorder association)

Beyond the preview

Go deeper on Ankyrin repeat and SOCS box protein 1 (ASB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and SOCS box protein 1 (ASB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call